Chinese hospital chain specializing in neurosurgery and brain/nervous-system disease treatment.
Chinese hospital chain specializing in neurosurgery and brain/nervous-system disease treatment.
Earns fees from patients, with inpatient surgery and treatment the largest part, paid partly through state medical insurance and partly out of pocket, and grows by opening or acquiring hospitals that take time to fill up and reach profit. Its brain-surgery reputation draws patients from across China.
In one line: A Chinese neurosurgery-focused hospital chain.
Moat: narrow (brand, process know-how). Specialized neurosurgical expertise and reputation versus general hospitals.
Headquarters: Beijing, China · Employees: 2,889
Size Sanbo Hospital Management (301293.SZ) is a China Health Care company (Hospital/Nursing Management) with a market value of $1.35B, the 1674th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥47.86 on 18 Nov 2026.
Performance Over six months the shares fell 28.8%, against -3.8% for the median peer and -20.0% for the China market (cap-weighted) — 2nd lowest of 20 in its peer set.
Growth Revenue grew 17.5% over the last twelve months (peer median +8.7%); the operating margin is 5.8% (peer median 10.0%).
Valuation It trades at 135.5× forward earnings against a peer median of 28.9× (2nd most expensive of 17).
Capital Return on invested capital runs 4.7 points below its cost of capital (10.4% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.93B | CN¥1.72B | CN¥1.43B | CN¥1.31B | CN¥1.07B |
| Revenue growth | — | +21% | +9% | +23% | — |
| Gross profit | CN¥527M | CN¥376M | CN¥325M | CN¥284M | CN¥217M |
| EBITDA | n/a | CN¥271M | CN¥229M | CN¥214M | CN¥181M |
| Net income | CN¥68.3M | CN¥84.2M | CN¥105M | CN¥78.2M | CN¥63.4M |
| Free cash flow | -CN¥38.2M | -CN¥396M | -CN¥371M | CN¥80.9M | CN¥67.2M |
| Capital expenditure | CN¥321M | CN¥586M | CN¥542M | CN¥170M | CN¥90.0M |
| Total debt | CN¥700M | CN¥632M | CN¥277M | CN¥174M | CN¥219M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Sanbo Hospital Management 301293.SZ | $1.35B | -29% | +17% | 6% | 135.5× | n/a |
| Aier Eye Hospital 300015.SZ | $12.5B | -14% | +5% | 21% | 30.1× | 11.8% |
| Huaxia Eye Hospital 301267.SZ | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301293.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.2% | +1.6% | 9th lowest of 20 |
| 6-month return | -28.8% | -3.8% | 2nd lowest of 20 |
| Distance from 52-week high | -53.5% | -21.9% | lowest of 21 |
| Revenue growth (TTM) | +17.5% | +8.7% | 6th highest of 21 |
| Operating margin | 5.8% | 10.0% | 6th lowest of 21 |
| Forward P/E | 135.5× | 28.9× | 2nd most expensive of 17 |
| ROIC minus cost of capital | -4.7 pp | -2.2 pp | 5th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 27.1× | -2.7% | +6.1% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 14.6× | 14.2% | +6.9% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 49.4× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | n/a | 6.1% | +6.0% |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | n/a | n/a | n/a |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 88.8× | n/a | n/a |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | n/a | 21.2% | +11.8% |
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% | +8.7% |
| Brookdale Senior Living BKD | United States | $2.06B | -36% | -8% | 6% | 482.6× | 19.3% | -1.4% |